In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSarepta CEO on what's next after expanded muscular dystrophy drug approvalDouglas Ingram, Sarepta CEO, joins 'Fast Money' to talk FDA approval of Elevidys and its impact on the company's stock.
Persons:
what's, Douglas Ingram